Nu Skin Enterprises
NUS

Nu Skin Enterprises (NUS) stock price, chart and financials

Price chart

−52.25% over 1Y
Oct 13, 2025Low $4.53 · High $11.54Oct 13, 2026

Financials

Net margin
−15.73%

Company profile

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

Frequently asked questions

  • Is Nu Skin Enterprises (NUS) profitable?

    No. Nu Skin Enterprises reported a net loss of $216.4M over the trailing twelve months.

  • How much revenue does Nu Skin Enterprises (NUS) make?

    Nu Skin Enterprises generated $1.4B in revenue over the trailing twelve months, down 17.10% year over year.

  • How do I buy stock in Nu Skin Enterprises (NUS)?

    NUS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.